Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B: week 144 results from a real‐world, multi‐centre cohort study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B: week 144 results from a real‐world, multi‐centre cohort study
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 56, Issue 4, Pages 713-722
Publisher
Wiley
Online
2022-06-23
DOI
10.1111/apt.17107
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study
- (2022) Eiichi Ogawa et al. Hepatology International
- Switching from entecavir to tenofovir alafenamide for chronic hepatitis B patients with low‐level viraemia
- (2021) Zhong‐Bin Li et al. LIVER INTERNATIONAL
- Treatment and renal outcomes up to 96 weeks after tenofovir alafenamide switch from tenofovir disoproxil fumarate in routine practice
- (2021) Hidenori Toyoda et al. HEPATOLOGY
- Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching from Tenofovir Disoproxil Fumarate
- (2021) Kwan Soo Byun et al. Clinical Gastroenterology and Hepatology
- Comparison of efficacy and safety of entecavir and switching from entecavir to tenofovir alafenamide fumarate in chronic hepatitis B: Long‐term effects from a prospective study
- (2021) Satoru Hagiwara et al. HEPATOLOGY RESEARCH
- Hepatitis B Virus Infection and Extra-Hepatic Manifestations: A Systemic Disease
- (2021) Patrice Cacoub et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Body weight changes in treated hepatitis B patients switching to tenofovir alafenamide☆
- (2021) Ming-Lun Yeh et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study
- (2020) Pietro Lampertico et al. Lancet Gastroenterology & Hepatology
- An aging population of chronic hepatitis B with increasing co-morbidities - a territory-wide study from 2000 to 2017
- (2019) Grace Lai-Hung Wong et al. HEPATOLOGY
- Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate
- (2019) Yoshihito Uchida et al. JOURNAL OF MEDICAL VIROLOGY
- Risk factors associated with hypophosphatemia in chronic Hepatitis B patients treated with tenofovir disoproxil fumarate
- (2019) Dohyeong Lee et al. MEDICINE
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- 96 weeks treatment of tenofovir alafenamide vs . tenofovir disoproxil fumarate for hepatitis B virus infection
- (2018) Kosh Agarwal et al. JOURNAL OF HEPATOLOGY
- Advancing age and comorbidity in a United States insured population-based cohort of patients with chronic hepatitis B
- (2018) Mindie H Nguyen et al. HEPATOLOGY
- A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015–2017
- (2018) Mario Gomez et al. INFECTION
- Improvement of bone mineral density and markers of proximal renal tubular function in chronic hepatitis B patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide
- (2018) Tse-Ling Fong et al. JOURNAL OF VIRAL HEPATITIS
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
- (2017) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects with Severe Renal Impairment
- (2016) Joseph M. Custodio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
- (2015) S. K. Sarin et al. Hepatology International
- Assessment of Bone Mineral Density in Tenofovir-Treated Patients With Chronic Hepatitis B: Can the Fracture Risk Assessment Tool Identify Those at Greatest Risk?
- (2014) Upkar S. Gill et al. JOURNAL OF INFECTIOUS DISEASES
- Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B
- (2012) N. Gara et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Revised Equations for Estimated GFR From Serum Creatinine in Japan
- (2009) Seiichi Matsuo et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy
- (2009) Daniel J. Tenney et al. HEPATOLOGY
- Tenofovir-Associated Fanconi Syndrome: Review of the FDA Adverse Event Reporting System
- (2008) Samir K. Gupta AIDS PATIENT CARE AND STDS
- Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response
- (2008) Carl J. Baldick et al. JOURNAL OF HEPATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started